NVIDIA Corporation (NVDA)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 14,510.00 |
|---|---|
| 52-week range | 10,140.00 – 16,320.00 |
| Return, 1 month / 3 months | −5.1% / +4.5% |
| Return, 1 year / 3 years | +20.4% / +734.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 36.1% |
| Worst drawdown (1 year) | -22.4% |
| Average daily value traded | 9,432.82M ARS |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NVIDIA Corporation designs and supplies graphics processing units and related hardware and software. Its chips power personal computers for gaming, workstations for professional design, and data centres used for artificial intelligence and cloud computing. The company also provides networking products and software platforms for developers and enterprises. NVIDIA is based in Santa Clara, California, and its products are used by gamers, researchers, designers and technology companies around the world.
The shares are listed on the Buenos Aires Exchange in Argentina under the code NVDA, and the price on this page is in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NVIDIA Corporation (NVDA) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 14,510.00 on 22 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 31 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.4% and over the last three months it rose 4.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.3% | ||
| From 52-week high | -9.9% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.5% | ||
| 6-month return | 17.5% | ||
| 12-month return, skipping the last month | 26.9% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.4% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 9,432.82M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −5.1% |
| 3 months | +4.5% |
| 6 months | +17.5% |
| 1 year | +20.4% |
| 3 years | +734.4% |
| 5 years | +7,614.5% |
Signals
| 50-day / 200-day average | 14,896.36 / 13,036.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 421.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | ARS 15.8078 |
| 4 Jun 2026 | ARS 15.8078 |
| 11 Mar 2026 | ARS 0.6328 |
| 4 Dec 2025 | ARS 0.6328 |
| 11 Sep 2025 | ARS 0.6328 |
| 11 Jun 2025 | ARS 0.6328 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.